查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1676732

质体定序市场总量：按组件、技术、样本类型、应用和最终用户划分 - 2025-2030 年全球预测

Whole Plasmid Sequencing Market by Component, Technology, Sample Type, Application, End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2024 年质体定序市场总量为 1.2735 亿美元，预计到 2025 年将成长至 1.3666 亿美元，复合年增长率为 7.71%，预计到 2030 年将达到 1.9888 亿美元。

主要市场统计数据
基准年 2024 年 1.2735亿美元
预计 2025 年 1.3666亿美元
预测年份 2030 1.9888亿美元
复合年增长率（%） 7.71％

全质体定序已成为分子生物学的基石，为遗传结构及其功能提供了前所未有的洞见。在当今快节奏的研究环境中，快速且准确的定序方法对于促进我们对基因表现、突变检测以及微生物和人类遗传学的整体动态的理解至关重要。该技术不仅将加速生物医学领域的发现，还将为个人化医疗、创新药物开发和尖端生物技术应用奠定基础。在过去十年中，定序技术的改进简化了工作流程并降低了成本，使研究人员能够以更高的准确性和有效性解决复杂的生物学问题。随着研究重点转向综合体学学方法，全质体定序的作用变得更加重要，为基础研究和临床诊断提供了全面的工具。

全质体定序的变革性影响体现在科学探索的多个方面，从详细的基因图谱到生物过程的即时分析。研究和行业专业人士现在可以使用的工具不仅可以提高资料的准确性，还可以为基因分析带来更高的解析度。这种模式转移将重新定义样品製备、资料管理和结果解释的最佳实践，为研究品质和临床应用设定新的标准。

改变整个质体定序市场

随着技术创新不断重新定义科学可能性的边界，定序领域正在发生重大变革时期。自动化和小型化的新进展，加上强大的生物资讯平台的集成，导致所有质体定序应用的通量和准确性显着提高。一个显着的变化是高解析度定序技术和分析工具的融合，将复杂的资料集简化为可操作的见解。这些发展不仅提高了研究业务的整体效率，也为个人化和精准医疗开闢了新的途径。

调查方法继续朝着更全面的方法发展，其中整合平台将样品处理、定序和资料分析结合在无缝的工作流程中。这项进步将支持快速诊断并实现对基因突变的即时监测。研究人员现在可以更好地管理大型资料，减少週转时间，并最终更有信心地推动基于证据的决策。次世代定序仪的增强、耗材的改进和全面的服务支援正在推动该行业走向更灵活、响应更快的未来。

对市场动态的关键细分洞察

详细观察市场细分可以发现几个有助于全质体定序策略决策的关键方面。基于组件的分析显示出多种焦点，包括消耗品、设备和服务。在此背景下，耗材进一步扩大到文库製备试剂套件和试剂，而设备则明确区分为分析仪和定序仪。市场上的服务分为资料分析服务和排序服务，每种服务在整个生态系统中都发挥独特的作用。进一步依照技术细分，突显了奈米孔定序、次世代定序、质体EZ和引子步行等技术的竞争。这些技术允许使用者根据速度、准确性和所需分析的复杂性等因素选择平台。

此外，按样本类型细分可以对血液、唾液和组织样本进行客製化分析，每种样本都需要不同的调查方法才能获得最佳表现。此外，全面的基于应用的评估揭示了疾病诊断和基因研究的差异化方法，并揭示了每个类别内的细微差别。在疾病诊断方面，癌症研究将进一步与神经退化性疾病区分，而遗传学研究将分为基因图谱和突变检测。最后，按最终用户细分，突出了学术研究机构、生物技术公司、临床研究组织和製药公司的不同需求。这种全面的细分方法不仅使市场参与企业能够识别潜在的成长领域，而且还可以帮助他们根据不断变化的用户需求和技术进步来客製化解决方案。

目录

第 1 章 简介

第二章调查方法

第三章执行摘要

第四章 市场概况

第五章 市场洞察

  • 市场动态
    • 驱动程式
      • 遗传疾病盛行率不断上升
      • 生物技术领域对先进基因组监测技术的需求日益增加
      • 政府采取措施促进基因工程和生物技术研发
    • 限制因素
      • 严格遵守全质体定序技术实施的法规
    • 机会
      • 定序技术不断进步
      • 定序技术前沿研究的资金和津贴激增
    • 任务
      • 替代测序技术的可用性
  • 市场区隔分析
    • 建构模组：提高解读复杂质体结构的工具的适用性
    • 应用：全质体定序在癌症研究和神经退化性疾病的重要性日益增加
  • 波特五力分析
  • PESTEL 分析
    • 政治的
    • 经济
    • 社会
    • 技术的
    • 合法的
    • 环境

6.质体定序市场整体状况（依组成部分）

  • 耗材
    • 文库製备试剂套件
    • 试剂
  • 装置
    • 分析器
    • 定序仪
  • 服务
    • 资料分析服务
    • 定序服务

7.质体定序市场整体状况（依技术划分）

  • 奈米孔定序
  • 次世代定序
  • 质体EZ
  • 入门步行

8.质体定序市场总体状况（依样本类型）

  • 血
  • 唾液
  • 组织

9.质体定序市场整体状况（依应用）

  • 疾病诊断
    • 癌症研究
    • 神经退化性疾病
  • 基因研究
    • 基因图谱
    • 突变检测

第 10质体。

  • 学术研究所
  • 生技公司
  • 临床研究所
  • 製药公司

11. 美洲质体定序市场总量

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

12. 亚太地区全质体定序市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

13. 欧洲、中东和非洲质体定序市场总量

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十四章 竞争格局

  • 2024 年市场占有率分析
  • FPNV 定位矩阵，2024 年
  • 竞争情境分析
  • 战略分析与建议

公司列表

  • Agilent Technologies, Inc.
  • Azenta Life Sciences
  • BaseClear BV
  • BGI Genomics Co., Ltd.
  • Bio-Rad Laboratories, Inc.
  • CD Genomics
  • Danaher Corporation
  • Eurofins Genomics LLC
  • F. Hoffmann-La Roche AG
  • GenScript Biotech Corporation
  • Illumina, Inc.
  • Integrated DNA Technologies
  • LGC Biosearch Technologies
  • Macrogen, Inc.
  • New England Biolabs
  • Novogene Co., Ltd.
  • Oxford Nanopore Technologies
  • Pacific Biosciences of California, Inc.
  • Paragon Genomics, Inc.
  • Personalis Inc.
  • Polyplus-transfection SA
  • Qiagen NV
  • Synthego Corporation
  • Takara Bio Inc.
  • Thermo Fisher Scientific Inc.
Product Code: MRR-0A3806951AC5

The Whole Plasmid Sequencing Market was valued at USD 127.35 million in 2024 and is projected to grow to USD 136.66 million in 2025, with a CAGR of 7.71%, reaching USD 198.88 million by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 127.35 million
Estimated Year [2025] USD 136.66 million
Forecast Year [2030] USD 198.88 million
CAGR (%) 7.71%

Whole plasmid sequencing has emerged as a cornerstone in molecular biology, offering unprecedented insights into genetic constructs and their functionalities. In today's fast-paced research environment, rapid and accurate sequencing methodologies are critical for advancing our understanding of gene expression, mutation detection, and the overall dynamics of microbial and human genetics. This technology not only accelerates discoveries in the biomedical sphere but also lays the groundwork for personalized medicine, innovative drug development, and cutting-edge biotechnological applications. Over the past decade, improvements in sequencing techniques have streamlined workflows and reduced costs, thereby enabling researchers to address complex biological questions with greater precision and effectiveness. As research priorities shift towards integrated omics approaches, the role of whole plasmid sequencing becomes even more vital, offering a comprehensive tool for both fundamental research and clinical diagnostics.

The transformational impact of whole plasmid sequencing is evident across several facets of scientific inquiry, from detailed genetic mapping to real-time analysis of biological processes. Researchers and industry experts alike now have access to tools that not only enhance data accuracy but also bring a higher degree of resolution to gene analysis. This paradigm shift is redefining best practices in sample preparation, data management, and result interpretation, setting a new standard for research quality and clinical applicability.

Transformative Shifts in the Sequencing Landscape

The sequencing landscape is undergoing significant transformation as technological innovations continuously redefine the boundaries of what is scientifically possible. Emerging advancements in automation and miniaturization, coupled with the integration of robust bioinformatics platforms, have led to a marked increase in throughput and accuracy in whole plasmid sequencing applications. A notable shift is the convergence of high-resolution sequencing technology with analytical tools that streamline complex data sets into actionable insights. These developments have not only enhanced the overall efficiency of research operations but have also opened up new avenues in personalized and precision medicine.

There is an ongoing trend towards more holistic approaches in research methodologies, where integrated platforms combine sample processing, sequencing, and data analysis in a seamless workflow. This evolution supports rapid diagnostics and enables real-time monitoring of genetic variations. Researchers are now better equipped to manage large datasets, reduce turnaround times, and ultimately drive evidence-based decisions with greater confidence. The enhanced capabilities of next-generation sequencing instruments, improved consumable quality, and comprehensive service support are driving the industry towards a more agile and responsive future, where innovation is not just a possibility but a fundamental requirement for success.

Key Segmentation Insights for Market Dynamics

A meticulous examination of market segmentation reveals several crucial dimensions that inform strategic decision-making in whole plasmid sequencing. Analysis based on component indicates a diversified focus, encompassing consumables, instruments, and services. In this context, consumables further extend into library preparation kits and reagents, while instruments are clearly differentiated into analyzers and sequencers. Services in the market are segmented into data analysis offerings and sequencing services, each playing a unique role in the overall ecosystem. Further segmentation based on technology highlights the competition between nanopore sequencing, next-generation sequencing, plasmid-EZ, and primer walking. These technologies allow users to select platforms based on factors such as speed, accuracy, and the complexity of analysis required.

In addition, segmentation by sample type introduces another layer of insight where the analysis is tailored to blood, saliva, and tissue samples, each requiring distinct methodologies for optimal performance. Moreover, a thorough evaluation based on application reveals differentiated approaches for disease diagnosis and genetic research, with a nuanced breakdown within each category; disease diagnosis further differentiates cancer research and neurodegenerative diseases, while genetic research bifurcates into gene mapping and mutation detection. Finally, segmentation by end user underlines the diversified demand from academic research institutes, biotechnology companies, clinical research organizations, and pharmaceutical companies. These comprehensive segmentation approaches not only allow market players to identify potential growth areas but also help in tailoring solutions that align with evolving user needs and technological advancements.

Based on Component, market is studied across Consumables, Instruments, and Services. The Consumables is further studied across Library Preparation Kits and Reagents. The Instruments is further studied across Analyzers and Sequencers. The Services is further studied across Data Analysis Services and Sequencing Services.

Based on Technology, market is studied across Nanopore Sequencing, Next-Generation Sequencing, Plasmid-EZ, and Primer Walking.

Based on Sample Type, market is studied across Blood, Saliva, and Tissue.

Based on Application, market is studied across Disease Diagnosis and Genetic Research. The Disease Diagnosis is further studied across Cancer Research and Neurodegenerative Diseases. The Genetic Research is further studied across Gene Mapping and Mutation Detection.

Based on End User, market is studied across Academic Research Institutes, Biotechnology Companies, Clinical Research Organizations, and Pharmaceutical Companies.

Key Regional Insights in an Evolving Global Market

The global landscape for whole plasmid sequencing is marked by a diversity of market dynamics across different regions. In the Americas, robust research funding and a strong network of academic and clinical institutions underpin a vibrant market that is continually pushing the envelope in genetic research. Elsewhere, the Europe, Middle East & Africa region presents diverse opportunities, fueled by a combination of government initiatives, industry innovations, and a growing focus on precision medicine that supports advancements in sequencing technologies.

The Asia-Pacific market has emerged as a focal point for rapid technological adoption and significant investments in research infrastructure. This region is witnessing a surge in high-impact projects and collaborations aimed at harnessing advanced sequencing techniques for improved diagnostics and therapeutic development. Each of these regions boasts unique strengths that contribute to a competitive yet cooperative global marketplace, ensuring that the benefits of whole plasmid sequencing advancements are disseminated widely to enhance research outcomes and clinical practices worldwide.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Key Companies Driving Innovation and Market Leadership

The competitive landscape of whole plasmid sequencing is fueled by a host of key players who consistently push the boundaries of innovation and quality. Market leaders such as Agilent Technologies, Inc., Azenta Life Sciences, and BaseClear B.V. are at the forefront of developing robust sequencing platforms and complementary consumables. BGI Genomics Co., Ltd. and Bio-Rad Laboratories, Inc. have also carved out significant niches by offering state-of-the-art instruments and highly specialized services. In parallel, CD Genomics, Danaher Corporation, and Eurofins Genomics LLC contribute to the market with their focus on high-throughput sequencing systems and advanced analytical tools.

Further reinforcing the sector's momentum, companies such as F. Hoffmann-La Roche AG, GenScript Biotech Corporation, and Illumina, Inc. have set benchmarks in delivering both reliability and precision through their innovative product portfolios. Integrated DNA Technologies, LGC Biosearch Technologies, and Macrogen, Inc. provide comprehensive solutions that cater to a broad spectrum of research requirements. Additionally, firms like New England Biolabs, Novogene Co., Ltd., Oxford Nanopore Technologies, and Pacific Biosciences of California, Inc. are instrumental in advancing sequencing methodologies. Companies including Paragon Genomics, Inc., Personalis Inc., Polyplus-transfection S.A., Qiagen N.V., Synthego Corporation, Takara Bio Inc., and Thermo Fisher Scientific Inc. continue to propel the industry forward, ensuring that innovations in whole plasmid sequencing remain accessible, efficient, and clinically relevant.

The report delves into recent significant developments in the Whole Plasmid Sequencing Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., Azenta Life Sciences, BaseClear B.V., BGI Genomics Co., Ltd., Bio-Rad Laboratories, Inc., CD Genomics, Danaher Corporation, Eurofins Genomics LLC, F. Hoffmann-La Roche AG, GenScript Biotech Corporation, Illumina, Inc., Integrated DNA Technologies, LGC Biosearch Technologies, Macrogen, Inc., New England Biolabs, Novogene Co., Ltd., Oxford Nanopore Technologies, Pacific Biosciences of California, Inc., Paragon Genomics, Inc., Personalis Inc., Polyplus-transfection S.A., Qiagen N.V., Synthego Corporation, Takara Bio Inc., and Thermo Fisher Scientific Inc.. Actionable Recommendations for Industry Leaders

For industry leaders looking to capitalize on the transformative trends within the whole plasmid sequencing market, a proactive and multi-faceted approach is essential. Embracing advancements in sequencing technologies and integrating emerging methodologies into existing workflows can lead to significant improvements in data accuracy and turnaround times. Leaders are encouraged to invest in research and development aimed at reducing consumable costs while enhancing the performance of analytical instruments and supporting services.

Strategic collaborations between technology developers, academic institutions, and clinical organizations should be prioritized to foster an ecosystem that supports innovation and shared expertise. Further, it is crucial to develop customized solutions that cater to specific segmentation needs, including component specificity, sample type requirements, and application-driven approaches. By leveraging robust technologies such as nanopore sequencing and next-generation sequencing, companies can streamline processes and drive down costs, ultimately yielding a competitive advantage. The focus should also be placed on expanding market reach in high-growth regions and strengthening the value chain through integrated data analysis platforms. Continual evaluation of market demands coupled with agile product development will serve as key differentiators in an increasingly dynamic landscape.

Conclusion and Future Outlook

In summary, the evolving domain of whole plasmid sequencing is poised to redefine the paradigms of genetic research and clinical diagnostics. With rapid technological advancements, enhanced data accuracy, and significant cost efficiencies, this field stands at the intersection of innovation and application. The integration of diverse segmentation insights-from component and technology specifications to application and end-user requirements-coupled with dynamic regional influences and competitive market leadership, paints a promising picture for future developments.

As research institutions and industry leaders continue to harness the potential of high-throughput sequencing platforms, the opportunities to drive meaningful scientific discoveries will undoubtedly increase. The current trajectory hints at a future where whole plasmid sequencing not only supports groundbreaking research but also accelerates the transition from laboratory findings to tangible clinical applications. The collaborative spirit among key market players and the strategic emphasis on innovation solidify the outlook for a transformative era in plasmid sequencing.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of genetic disorders
      • 5.1.1.2. Growing demand for advanced genomic research techniques in biotechnology sector
      • 5.1.1.3. Government initiatives promoting research and development in genetic engineering and biotechnologies
    • 5.1.2. Restraints
      • 5.1.2.1. Stringent regulatory compliances for deployment of whole plasmid sequencing technologies
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing advancements in sequencing technologies
      • 5.1.3.2. Surge in funding and grants for advanced research in sequencing technologies
    • 5.1.4. Challenges
      • 5.1.4.1. Availability of alternative sequencing techniques
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Component: Rising preference for instruments for decoding complex plasmid structures
    • 5.2.2. Application: Increasing significance of whole plasmid sequencing for cancer research and neurodegenerative diseases
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Whole Plasmid Sequencing Market, by Component

  • 6.1. Introduction
  • 6.2. Consumables
    • 6.2.1. Library Preparation Kits
    • 6.2.2. Reagents
  • 6.3. Instruments
    • 6.3.1. Analyzers
    • 6.3.2. Sequencers
  • 6.4. Services
    • 6.4.1. Data Analysis Services
    • 6.4.2. Sequencing Services

7. Whole Plasmid Sequencing Market, by Technology

  • 7.1. Introduction
  • 7.2. Nanopore Sequencing
  • 7.3. Next-Generation Sequencing
  • 7.4. Plasmid-EZ
  • 7.5. Primer Walking

8. Whole Plasmid Sequencing Market, by Sample Type

  • 8.1. Introduction
  • 8.2. Blood
  • 8.3. Saliva
  • 8.4. Tissue

9. Whole Plasmid Sequencing Market, by Application

  • 9.1. Introduction
  • 9.2. Disease Diagnosis
    • 9.2.1. Cancer Research
    • 9.2.2. Neurodegenerative Diseases
  • 9.3. Genetic Research
    • 9.3.1. Gene Mapping
    • 9.3.2. Mutation Detection

10. Whole Plasmid Sequencing Market, by End User

  • 10.1. Introduction
  • 10.2. Academic Research Institutes
  • 10.3. Biotechnology Companies
  • 10.4. Clinical Research Organizations
  • 10.5. Pharmaceutical Companies

11. Americas Whole Plasmid Sequencing Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Whole Plasmid Sequencing Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Whole Plasmid Sequencing Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2024
  • 14.2. FPNV Positioning Matrix, 2024
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. Oxford Nanopore Technologies and Plasmidsaurus team up to enhance plasmid sequencing with advanced nanopore technology.
    • 14.3.2. seqWell transforms synthetic biology with ExpressPlex HT enabling ultra-high throughput plasmid sequencing
    • 14.3.3. Eurofins Genomics enhances genetic research capabilities with new Seattle lab utilizing Oxford Nanopore
  • 14.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Agilent Technologies, Inc.
  • 2. Azenta Life Sciences
  • 3. BaseClear B.V.
  • 4. BGI Genomics Co., Ltd.
  • 5. Bio-Rad Laboratories, Inc.
  • 6. CD Genomics
  • 7. Danaher Corporation
  • 8. Eurofins Genomics LLC
  • 9. F. Hoffmann-La Roche AG
  • 10. GenScript Biotech Corporation
  • 11. Illumina, Inc.
  • 12. Integrated DNA Technologies
  • 13. LGC Biosearch Technologies
  • 14. Macrogen, Inc.
  • 15. New England Biolabs
  • 16. Novogene Co., Ltd.
  • 17. Oxford Nanopore Technologies
  • 18. Pacific Biosciences of California, Inc.
  • 19. Paragon Genomics, Inc.
  • 20. Personalis Inc.
  • 21. Polyplus-transfection S.A.
  • 22. Qiagen N.V.
  • 23. Synthego Corporation
  • 24. Takara Bio Inc.
  • 25. Thermo Fisher Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. WHOLE PLASMID SEQUENCING MARKET MULTI-CURRENCY
  • FIGURE 2. WHOLE PLASMID SEQUENCING MARKET MULTI-LANGUAGE
  • FIGURE 3. WHOLE PLASMID SEQUENCING MARKET RESEARCH PROCESS
  • FIGURE 4. WHOLE PLASMID SEQUENCING MARKET SIZE, 2024 VS 2030
  • FIGURE 5. GLOBAL WHOLE PLASMID SEQUENCING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 6. GLOBAL WHOLE PLASMID SEQUENCING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL WHOLE PLASMID SEQUENCING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL WHOLE PLASMID SEQUENCING MARKET SIZE, BY COMPONENT, 2024 VS 2030 (%)
  • FIGURE 9. GLOBAL WHOLE PLASMID SEQUENCING MARKET SIZE, BY COMPONENT, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL WHOLE PLASMID SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
  • FIGURE 11. GLOBAL WHOLE PLASMID SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL WHOLE PLASMID SEQUENCING MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2030 (%)
  • FIGURE 13. GLOBAL WHOLE PLASMID SEQUENCING MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL WHOLE PLASMID SEQUENCING MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
  • FIGURE 15. GLOBAL WHOLE PLASMID SEQUENCING MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 16. GLOBAL WHOLE PLASMID SEQUENCING MARKET SIZE, BY END USER, 2024 VS 2030 (%)
  • FIGURE 17. GLOBAL WHOLE PLASMID SEQUENCING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 18. AMERICAS WHOLE PLASMID SEQUENCING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 19. AMERICAS WHOLE PLASMID SEQUENCING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 20. UNITED STATES WHOLE PLASMID SEQUENCING MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 21. UNITED STATES WHOLE PLASMID SEQUENCING MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC WHOLE PLASMID SEQUENCING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 23. ASIA-PACIFIC WHOLE PLASMID SEQUENCING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 24. EUROPE, MIDDLE EAST & AFRICA WHOLE PLASMID SEQUENCING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 25. EUROPE, MIDDLE EAST & AFRICA WHOLE PLASMID SEQUENCING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 26. WHOLE PLASMID SEQUENCING MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 27. WHOLE PLASMID SEQUENCING MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. WHOLE PLASMID SEQUENCING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL WHOLE PLASMID SEQUENCING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL WHOLE PLASMID SEQUENCING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL WHOLE PLASMID SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. WHOLE PLASMID SEQUENCING MARKET DYNAMICS
  • TABLE 7. GLOBAL WHOLE PLASMID SEQUENCING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL WHOLE PLASMID SEQUENCING MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL WHOLE PLASMID SEQUENCING MARKET SIZE, BY LIBRARY PREPARATION KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL WHOLE PLASMID SEQUENCING MARKET SIZE, BY REAGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL WHOLE PLASMID SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL WHOLE PLASMID SEQUENCING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL WHOLE PLASMID SEQUENCING MARKET SIZE, BY ANALYZERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL WHOLE PLASMID SEQUENCING MARKET SIZE, BY SEQUENCERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL WHOLE PLASMID SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL WHOLE PLASMID SEQUENCING MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL WHOLE PLASMID SEQUENCING MARKET SIZE, BY DATA ANALYSIS SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL WHOLE PLASMID SEQUENCING MARKET SIZE, BY SEQUENCING SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL WHOLE PLASMID SEQUENCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL WHOLE PLASMID SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL WHOLE PLASMID SEQUENCING MARKET SIZE, BY NANOPORE SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL WHOLE PLASMID SEQUENCING MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL WHOLE PLASMID SEQUENCING MARKET SIZE, BY PLASMID-EZ, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL WHOLE PLASMID SEQUENCING MARKET SIZE, BY PRIMER WALKING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL WHOLE PLASMID SEQUENCING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL WHOLE PLASMID SEQUENCING MARKET SIZE, BY BLOOD, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL WHOLE PLASMID SEQUENCING MARKET SIZE, BY SALIVA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL WHOLE PLASMID SEQUENCING MARKET SIZE, BY TISSUE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL WHOLE PLASMID SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL WHOLE PLASMID SEQUENCING MARKET SIZE, BY DISEASE DIAGNOSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL WHOLE PLASMID SEQUENCING MARKET SIZE, BY CANCER RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL WHOLE PLASMID SEQUENCING MARKET SIZE, BY NEURODEGENERATIVE DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL WHOLE PLASMID SEQUENCING MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL WHOLE PLASMID SEQUENCING MARKET SIZE, BY GENETIC RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL WHOLE PLASMID SEQUENCING MARKET SIZE, BY GENE MAPPING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL WHOLE PLASMID SEQUENCING MARKET SIZE, BY MUTATION DETECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL WHOLE PLASMID SEQUENCING MARKET SIZE, BY GENETIC RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL WHOLE PLASMID SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL WHOLE PLASMID SEQUENCING MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL WHOLE PLASMID SEQUENCING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL WHOLE PLASMID SEQUENCING MARKET SIZE, BY CLINICAL RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 42. GLOBAL WHOLE PLASMID SEQUENCING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 43. AMERICAS WHOLE PLASMID SEQUENCING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 44. AMERICAS WHOLE PLASMID SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 45. AMERICAS WHOLE PLASMID SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 46. AMERICAS WHOLE PLASMID SEQUENCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 47. AMERICAS WHOLE PLASMID SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 48. AMERICAS WHOLE PLASMID SEQUENCING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. AMERICAS WHOLE PLASMID SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. AMERICAS WHOLE PLASMID SEQUENCING MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 51. AMERICAS WHOLE PLASMID SEQUENCING MARKET SIZE, BY GENETIC RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 52. AMERICAS WHOLE PLASMID SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 53. AMERICAS WHOLE PLASMID SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 54. ARGENTINA WHOLE PLASMID SEQUENCING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 55. ARGENTINA WHOLE PLASMID SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 56. ARGENTINA WHOLE PLASMID SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 57. ARGENTINA WHOLE PLASMID SEQUENCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 58. ARGENTINA WHOLE PLASMID SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 59. ARGENTINA WHOLE PLASMID SEQUENCING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. ARGENTINA WHOLE PLASMID SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. ARGENTINA WHOLE PLASMID SEQUENCING MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 62. ARGENTINA WHOLE PLASMID SEQUENCING MARKET SIZE, BY GENETIC RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 63. ARGENTINA WHOLE PLASMID SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 64. BRAZIL WHOLE PLASMID SEQUENCING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 65. BRAZIL WHOLE PLASMID SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 66. BRAZIL WHOLE PLASMID SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 67. BRAZIL WHOLE PLASMID SEQUENCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 68. BRAZIL WHOLE PLASMID SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 69. BRAZIL WHOLE PLASMID SEQUENCING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. BRAZIL WHOLE PLASMID SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. BRAZIL WHOLE PLASMID SEQUENCING MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 72. BRAZIL WHOLE PLASMID SEQUENCING MARKET SIZE, BY GENETIC RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 73. BRAZIL WHOLE PLASMID SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 74. CANADA WHOLE PLASMID SEQUENCING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 75. CANADA WHOLE PLASMID SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 76. CANADA WHOLE PLASMID SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 77. CANADA WHOLE PLASMID SEQUENCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 78. CANADA WHOLE PLASMID SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 79. CANADA WHOLE PLASMID SEQUENCING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. CANADA WHOLE PLASMID SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. CANADA WHOLE PLASMID SEQUENCING MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 82. CANADA WHOLE PLASMID SEQUENCING MARKET SIZE, BY GENETIC RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 83. CANADA WHOLE PLASMID SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 84. MEXICO WHOLE PLASMID SEQUENCING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 85. MEXICO WHOLE PLASMID SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 86. MEXICO WHOLE PLASMID SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 87. MEXICO WHOLE PLASMID SEQUENCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 88. MEXICO WHOLE PLASMID SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 89. MEXICO WHOLE PLASMID SEQUENCING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. MEXICO WHOLE PLASMID SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. MEXICO WHOLE PLASMID SEQUENCING MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 92. MEXICO WHOLE PLASMID SEQUENCING MARKET SIZE, BY GENETIC RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 93. MEXICO WHOLE PLASMID SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 94. UNITED STATES WHOLE PLASMID SEQUENCING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 95. UNITED STATES WHOLE PLASMID SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED STATES WHOLE PLASMID SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED STATES WHOLE PLASMID SEQUENCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED STATES WHOLE PLASMID SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED STATES WHOLE PLASMID SEQUENCING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED STATES WHOLE PLASMID SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. UNITED STATES WHOLE PLASMID SEQUENCING MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 102. UNITED STATES WHOLE PLASMID SEQUENCING MARKET SIZE, BY GENETIC RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 103. UNITED STATES WHOLE PLASMID SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 104. UNITED STATES WHOLE PLASMID SEQUENCING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 105. ASIA-PACIFIC WHOLE PLASMID SEQUENCING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 106. ASIA-PACIFIC WHOLE PLASMID SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 107. ASIA-PACIFIC WHOLE PLASMID SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 108. ASIA-PACIFIC WHOLE PLASMID SEQUENCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 109. ASIA-PACIFIC WHOLE PLASMID SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 110. ASIA-PACIFIC WHOLE PLASMID SEQUENCING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. ASIA-PACIFIC WHOLE PLASMID SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. ASIA-PACIFIC WHOLE PLASMID SEQUENCING MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 113. ASIA-PACIFIC WHOLE PLASMID SEQUENCING MARKET SIZE, BY GENETIC RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 114. ASIA-PACIFIC WHOLE PLASMID SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC WHOLE PLASMID SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 116. AUSTRALIA WHOLE PLASMID SEQUENCING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 117. AUSTRALIA WHOLE PLASMID SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 118. AUSTRALIA WHOLE PLASMID SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 119. AUSTRALIA WHOLE PLASMID SEQUENCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 120. AUSTRALIA WHOLE PLASMID SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 121. AUSTRALIA WHOLE PLASMID SEQUENCING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. AUSTRALIA WHOLE PLASMID SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. AUSTRALIA WHOLE PLASMID SEQUENCING MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 124. AUSTRALIA WHOLE PLASMID SEQUENCING MARKET SIZE, BY GENETIC RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 125. AUSTRALIA WHOLE PLASMID SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 126. CHINA WHOLE PLASMID SEQUENCING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 127. CHINA WHOLE PLASMID SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 128. CHINA WHOLE PLASMID SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 129. CHINA WHOLE PLASMID SEQUENCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 130. CHINA WHOLE PLASMID SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 131. CHINA WHOLE PLASMID SEQUENCING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. CHINA WHOLE PLASMID SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 133. CHINA WHOLE PLASMID SEQUENCING MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 134. CHINA WHOLE PLASMID SEQUENCING MARKET SIZE, BY GENETIC RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 135. CHINA WHOLE PLASMID SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 136. INDIA WHOLE PLASMID SEQUENCING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 137. INDIA WHOLE PLASMID SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 138. INDIA WHOLE PLASMID SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 139. INDIA WHOLE PLASMID SEQUENCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 140. INDIA WHOLE PLASMID SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 141. INDIA WHOLE PLASMID SEQUENCING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. INDIA WHOLE PLASMID SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. INDIA WHOLE PLASMID SEQUENCING MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 144. INDIA WHOLE PLASMID SEQUENCING MARKET SIZE, BY GENETIC RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 145. INDIA WHOLE PLASMID SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 146. INDONESIA WHOLE PLASMID SEQUENCING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 147. INDONESIA WHOLE PLASMID SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 148. INDONESIA WHOLE PLASMID SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 149. INDONESIA WHOLE PLASMID SEQUENCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 150. INDONESIA WHOLE PLASMID SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 151. INDONESIA WHOLE PLASMID SEQUENCING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 152. INDONESIA WHOLE PLASMID SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 153. INDONESIA WHOLE PLASMID SEQUENCING MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 154. INDONESIA WHOLE PLASMID SEQUENCING MARKET SIZE, BY GENETIC RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 155. INDONESIA WHOLE PLASMID SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 156. JAPAN WHOLE PLASMID SEQUENCING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 157. JAPAN WHOLE PLASMID SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 158. JAPAN WHOLE PLASMID SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 159. JAPAN WHOLE PLASMID SEQUENCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 160. JAPAN WHOLE PLASMID SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 161. JAPAN WHOLE PLASMID SEQUENCING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 162. JAPAN WHOLE PLASMID SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 163. JAPAN WHOLE PLASMID SEQUENCING MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 164. JAPAN WHOLE PLASMID SEQUENCING MARKET SIZE, BY GENETIC RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 165. JAPAN WHOLE PLASMID SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 166. MALAYSIA WHOLE PLASMID SEQUENCING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 167. MALAYSIA WHOLE PLASMID SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 168. MALAYSIA WHOLE PLASMID SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 169. MALAYSIA WHOLE PLASMID SEQUENCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 170. MALAYSIA WHOLE PLASMID SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 171. MALAYSIA WHOLE PLASMID SEQUENCING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. MALAYSIA WHOLE PLASMID SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 173. MALAYSIA WHOLE PLASMID SEQUENCING MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 174. MALAYSIA WHOLE PLASMID SEQUENCING MARKET SIZE, BY GENETIC RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 175. MALAYSIA WHOLE PLASMID SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 176. PHILIPPINES WHOLE PLASMID SEQUENCING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 177. PHILIPPINES WHOLE PLASMID SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 178. PHILIPPINES WHOLE PLASMID SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 179. PHILIPPINES WHOLE PLASMID SEQUENCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 180. PHILIPPINES WHOLE PLASMID SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 181. PHILIPPINES WHOLE PLASMID SEQUENCING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 182. PHILIPPINES WHOLE PLASMID SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 183. PHILIPPINES WHOLE PLASMID SEQUENCING MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 184. PHILIPPINES WHOLE PLASMID SEQUENCING MARKET SIZE, BY GENETIC RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 185. PHILIPPINES WHOLE PLASMID SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 186. SINGAPORE WHOLE PLASMID SEQUENCING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 187. SINGAPORE WHOLE PLASMID SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 188. SINGAPORE WHOLE PLASMID SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 189. SINGAPORE WHOLE PLASMID SEQUENCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 190. SINGAPORE WHOLE PLASMID SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 191. SINGAPORE WHOLE PLASMID SEQUENCING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 192. SINGAPORE WHOLE PLASMID SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 193. SINGAPORE WHOLE PLASMID SEQUENCING MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 194. SINGAPORE WHOLE PLASMID SEQUENCING MARKET SIZE, BY GENETIC RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 195. SINGAPORE WHOLE PLASMID SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 196. SOUTH KOREA WHOLE PLASMID SEQUENCING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 197. SOUTH KOREA WHOLE PLASMID SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 198. SOUTH KOREA WHOLE PLASMID SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 199. SOUTH KOREA WHOLE PLASMID SEQUENCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 200. SOUTH KOREA WHOLE PLASMID SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 201. SOUTH KOREA WHOLE PLASMID SEQUENCING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 202. SOUTH KOREA WHOLE PLASMID SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH KOREA WHOLE PLASMID SEQUENCING MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 204. SOUTH KOREA WHOLE PLASMID SEQUENCING MARKET SIZE, BY GENETIC RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 205. SOUTH KOREA WHOLE PLASMID SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 206. TAIWAN WHOLE PLASMID SEQUENCING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 207. TAIWAN WHOLE PLASMID SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 208. TAIWAN WHOLE PLASMID SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 209. TAIWAN WHOLE PLASMID SEQUENCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 210. TAIWAN WHOLE PLASMID SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 211. TAIWAN WHOLE PLASMID SEQUENCING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 212. TAIWAN WHOLE PLASMID SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 213. TAIWAN WHOLE PLASMID SEQUENCING MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 214. TAIWAN WHOLE PLASMID SEQUENCING MARKET SIZE, BY GENETIC RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 215. TAIWAN WHOLE PLASMID SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 216. THAILAND WHOLE PLASMID SEQUENCING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 217. THAILAND WHOLE PLASMID SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 218. THAILAND WHOLE PLASMID SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 219. THAILAND WHOLE PLASMID SEQUENCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 220. THAILAND WHOLE PLASMID SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 221. THAILAND WHOLE PLASMID SEQUENCING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 222. THAILAND WHOLE PLASMID SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 223. THAILAND WHOLE PLASMID SEQUENCING MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 224. THAILAND WHOLE PLASMID SEQUENCING MARKET SIZE, BY GENETIC RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 225. THAILAND WHOLE PLASMID SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 226. VIETNAM WHOLE PLASMID SEQUENCING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 227. VIETNAM WHOLE PLASMID SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 228. VIETNAM WHOLE PLASMID SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 229. VIETNAM WHOLE PLASMID SEQUENCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 230. VIETNAM WHOLE PLASMID SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 231. VIETNAM WHOLE PLASMID SEQUENCING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 232. VIETNAM WHOLE PLASMID SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 233. VIETNAM WHOLE PLASMID SEQUENCING MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 234. VIETNAM WHOLE PLASMID SEQUENCING MARKET SIZE, BY GENETIC RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 235. VIETNAM WHOLE PLASMID SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 236. EUROPE, MIDDLE EAST & AFRICA WHOLE PLASMID SEQUENCING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 237. EUROPE, MIDDLE EAST & AFRICA WHOLE PLASMID SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 238. EUROPE, MIDDLE EAST & AFRICA WHOLE PLASMID SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 239. EUROPE, MIDDLE EAST & AFRICA WHOLE PLASMID SEQUENCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 240. EUROPE, MIDDLE EAST & AFRICA WHOLE PLASMID SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 241. EUROPE, MIDDLE EAST & AFRICA WHOLE PLASMID SEQUENCING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 242. EUROPE, MIDDLE EAST & AFRICA WHOLE PLASMID SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 243. EUROPE, MIDDLE EAST & AFRICA WHOLE PLASMID SEQUENCING MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 244. EUROPE, MIDDLE EAST & AFRICA WHOLE PLASMID SEQUENCING MARKET SIZE, BY GENETIC RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 245. EUROPE, MIDDLE EAST & AFRICA WHOLE PLASMID SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 246. EUROPE, MIDDLE EAST & AFRICA WHOLE PLASMID SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 247. DENMARK WHOLE PLASMID SEQUENCING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 248. DENMARK WHOLE PLASMID SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 249. DENMARK WHOLE PLASMID SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 250. DENMARK WHOLE PLASMID SEQUENCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 251. DENMARK WHOLE PLASMID SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 252. DENMARK WHOLE PLASMID SEQUENCING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 253. DENMARK WHOLE PLASMID SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 254. DENMARK WHOLE PLASMID SEQUENCING MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 255. DENMARK WHOLE PLASMID SEQUENCING MARKET SIZE, BY GENETIC RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 256. DENMARK WHOLE PLASMID SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 257. EGYPT WHOLE PLASMID SEQUENCING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 258. EGYPT WHOLE PLASMID SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 259. EGYPT WHOLE PLASMID SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 260. EGYPT WHOLE PLASMID SEQUENCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 261. EGYPT WHOLE PLASMID SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 262. EGYPT WHOLE PLASMID SEQUENCING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 263. EGYPT WHOLE PLASMID SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 264. EGYPT WHOLE PLASMID SEQUENCING MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 265. EGYPT WHOLE PLASMID SEQUENCING MARKET SIZE, BY GENETIC RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 266. EGYPT WHOLE PLASMID SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 267. FINLAND WHOLE PLASMID SEQUENCING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 268. FINLAND WHOLE PLASMID SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 269. FINLAND WHOLE PLASMID SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 270. FINLAND WHOLE PLASMID SEQUENCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 271. FINLAND WHOLE PLASMID SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 272. FINLAND WHOLE PLASMID SEQUENCING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 273. FINLAND WHOLE PLASMID SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 274. FINLAND WHOLE PLASMID SEQUENCING MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 275. FINLAND WHOLE PLASMID SEQUENCING MARKET SIZE, BY GENETIC RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 276. FINLAND WHOLE PLASMID SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 277. FRANCE WHOLE PLASMID SEQUENCING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 278. FRANCE WHOLE PLASMID SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 279. FRANCE WHOLE PLASMID SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 280. FRANCE WHOLE PLASMID SEQUENCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 281. FRANCE WHOLE PLASMID SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 282. FRANCE WHOLE PLASMID SEQUENCING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 283. FRANCE WHOLE PLASMID SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 284. FRANCE WHOLE PLASMID SEQUENCING MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 285. FRANCE WHOLE PLASMID SEQUENCING MARKET SIZE, BY GENETIC RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 286. FRANCE WHOLE PLASMID SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 287. GERMANY WHOLE PLASMID SEQUENCING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 288. GERMANY WHOLE PLASMID SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 289. GERMANY WHOLE PLASMID SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 290. GERMANY WHOLE PLASMID SEQUENCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 291. GERMANY WHOLE PLASMID SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 292. GERMANY WHOLE PLASMID SEQUENCING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 293. GERMANY WHOLE PLASMID SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 294. GERMANY WHOLE PLASMID SEQUENCING MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 295. GERMANY WHOLE PLASMID SEQUENCING MARKET SIZE, BY GENETIC RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 296. GERMANY WHOLE PLASMID SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 297. ISRAEL WHOLE PLASMID SEQUENCING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 298. ISRAEL WHOLE PLASMID SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 299. ISRAEL WHOLE PLASMID SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 300. ISRAEL WHOLE PLASMID SEQUENCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 301. ISRAEL WHOLE PLASMID SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 302. ISRAEL WHOLE PLASMID SEQUENCING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 303. ISRAEL WHOLE PLASMID SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 304. ISRAEL WHOLE PLASMID SEQUENCING MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 305. ISRAEL WHOLE PLASMID SEQUENCING MARKET SIZE, BY GENETIC RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 306. ISRAEL WHOLE PLASMID SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 307. ITALY WHOLE PLASMID SEQUENCING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 308. ITALY WHOLE PLASMID SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 309. ITALY WHOLE PLASMID SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 310. ITALY WHOLE PLASMID SEQUENCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 311. ITALY WHOLE PLASMID SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 312. ITALY WHOLE PLASMID SEQUENCING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 313. ITALY WHOLE PLASMID SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 314. ITALY WHOLE PLASMID SEQUENCING MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 315. ITALY WHOLE PLASMID SEQUENCING MARKET SIZE, BY GENETIC RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 316. ITALY WHOLE PLASMID SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 317. NETHERLANDS WHOLE PLASMID SEQUENCING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 318. NETHERLANDS WHOLE PLASMID SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 319. NETHERLANDS WHOLE PLASMID SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 320. NETHERLANDS WHOLE PLASMID SEQUENCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 321. NETHERLANDS WHOLE PLASMID SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 322. NETHERLANDS WHOLE PLASMID SEQUENCING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 323. NETHERLANDS WHOLE PLASMID SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 324. NETHERLANDS WHOLE PLASMID SEQUENCING MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 325. NETHERLANDS WHOLE PLASMID SEQUENCING MARKET SIZE, BY GENETIC RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 326. NETHERLANDS WHOLE PLASMID SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 327. NIGERIA WHOLE PLASMID SEQUENCING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 328. NIGERIA WHOLE PLASMID SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 329. NIGERIA WHOLE PLASMID SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 330. NIGERIA WHOLE PLASMID SEQUENCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 331. NIGERIA WHOLE PLASMID SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 332. NIGERIA WHOLE PLASMID SEQUENCING MARKET SIZE, BY SAMPLE TYP